FREE SHIPPING ON ORDERS OVER $150

glp-1-directed nmda receptor antagonism for obesity treatment GLP−1 agonists the of obesity: Role as a promising approach Metabolic Flux Adaptations During GLP-1

$21.66

Quantity
- +
Description

Lifestyle factors influencing diabetes and depression Poor dietary habits Depression often leads to changes in appetite and eating behaviors, significantly contributing to the development of diabetes [34]

glp-1-directed nmda receptor antagonism for obesity treatment GLP1 agonists the of obesity: Role as a promising approach Metabolic Flux Adaptations During GLP-1

J Biol Chem (2004) 279(19):2034555

glp-1-directed nmda receptor antagonism for obesity treatment GLP1 agonists the of obesity: Role as a promising approach Metabolic Flux Adaptations During GLP-1

Dulaglutide is a long-acting GLP-1R agonist with a half-life of 4 days (124)

glp-1-directed nmda receptor antagonism for obesity treatment GLP1 agonists the of obesity: Role as a promising approach Metabolic Flux Adaptations During GLP-1

doi: 10.1016/j.cmet.2018.03.001 [DOI] [PubMed] [Google Scholar] 87.Cornell S

glp-1-directed nmda receptor antagonism for obesity treatment GLP1 agonists the of obesity: Role as a promising approach Metabolic Flux Adaptations During GLP-1

References Beaudry, J

glp-1-directed nmda receptor antagonism for obesity treatment GLP1 agonists the of obesity: Role as a promising approach Metabolic Flux Adaptations During GLP-1

You may also like

recommand products